The availability of antiretroviral therapy has dramatically reduced the risk of HIV mother-to-child transmission (MTCT). However, mothers infected with multidrug resistant HIV (MDR-HIV) are at increased risk of MTCT. We report the case of a pregnant patient infected with MDR-HIV in whom MTCT was avoided with enfuvirtide use in late pregnancy and elective caesarean section.
Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide use in late pregnancy / Madeddu, Giordano; Calia, Gm; Campus, Ml; Lovigu, C; Mannazzu, M; Olmeo, P; Mela, Mg; Mura, Maria Stella Anna. - In: INTERNATIONAL JOURNAL OF STD & AIDS. - ISSN 0956-4624. - 19:9(2008), pp. 644-645.
Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide use in late pregnancy
MADEDDU, Giordano;MURA, Maria Stella Anna
2008-01-01
Abstract
The availability of antiretroviral therapy has dramatically reduced the risk of HIV mother-to-child transmission (MTCT). However, mothers infected with multidrug resistant HIV (MDR-HIV) are at increased risk of MTCT. We report the case of a pregnant patient infected with MDR-HIV in whom MTCT was avoided with enfuvirtide use in late pregnancy and elective caesarean section.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
